AM, A., RM, K., ME, L., AZ, A., DH, E., AF, A., . . . AM, Y. (2022). RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications. Contemporary oncology (Poznan, Poland), 26(2), 109. https://doi.org/10.5114/wo.2022.118245
Chicago Style (17th ed.) CitationAM, Abdelbary, Kaf RM, Lashin ME, Alattar AZ, Elsayed DH, Amin AF, Gertallah LM, and Yehia AM. "RON, ROR1 and SUSD2 Expression in Tissues of Endometrial Carcinoma Patients. Clinicopathological and Prognostic Implications." Contemporary Oncology (Poznan, Poland) 26, no. 2 (2022): 109. https://doi.org/10.5114/wo.2022.118245.
MLA (9th ed.) CitationAM, Abdelbary, et al. "RON, ROR1 and SUSD2 Expression in Tissues of Endometrial Carcinoma Patients. Clinicopathological and Prognostic Implications." Contemporary Oncology (Poznan, Poland), vol. 26, no. 2, 2022, p. 109, https://doi.org/10.5114/wo.2022.118245.